A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial

Official title:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety and Tolerability, of ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Status Completed

Clinical Trial Summary

This trial will evaluate the effect of ASP7147 on daily abdominal pain due to IBS-D during 4 weeks of treatment. It will also evaluate safety and tolerability in patients with IBS-D over the 4-week treatment period.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Diarrhea
Diarrhea Predominant Irritable Bowel Syndrome
Irritable Bowel Syndrome
Syndrome

Clinical Trial Details

NCT number	NCT01896583
Study type	Interventional
Source	Seldar Pharma, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	November 2013
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02239926` - Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D	Phase 2/Phase 3
Completed	`NCT02251483` - Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth	N/A
Completed	`NCT01100684` - Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)	Phase 3
Completed	`NCT02728063` - Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance	N/A
Completed	`NCT02358694` - Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS	N/A
Recruiting	`NCT01637714` - The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome	N/A
Not yet recruiting	`NCT01373034` - The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome	N/A
Completed	`NCT01094041` - Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome	N/A
Completed	`NCT00616200` - Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)	N/A
Completed	`NCT02111603` - Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids	Phase 4